$ABT
ABBOTT LABORATORIES Stock $abt

$abt Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000162828023035957 Filed on November 01, 2023

Income Statement

Concept	2023 Q3
Revenue	$10.14B
YoY Change	-2.56%
Cost Of Revenue	$4.605B
YoY Change	-0.52%
Gross Profit	$5.538B
YoY Change	-4.2%
Gross Profit Margin	54.6%
Selling, General & Admin	$2.723B
YoY Change	1.15%
% of Gross Profit	49.17%
Research & Development	$672.0M
YoY Change	5.66%
% of Gross Profit	12.13%
Depreciation & Amortization	$824.0M
YoY Change	65.46%
% of Gross Profit	14.88%
Operating Expenses	$3.395B
YoY Change	-11.27%
Operating Profit	$1.647B
YoY Change	-15.75%
Interest Expense	$166.0M
YoY Change	-258.1%
% of Operating Profit	10.08%
Other Income/Expense, Net	$83.00M
YoY Change	-6.74%
Pretax Income	$1.671B
YoY Change	-4.95%
Income Tax	$235.0M
% Of Pretax Income	14.06%
Net Earnings	$1.436B
YoY Change	0.07%
Net Earnings / Revenue	14.16%
Basic Earnings Per Share	$0.82
Diluted Earnings Per Share	$0.82
COMMON SHARES
Basic Shares Outstanding	1.739B shares
Diluted Shares Outstanding	1.748B shares

Balance Sheet

Concept	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.047B
YoY Change	-28.87%
Cash & Equivalents	$6.709B
Short-Term Investments	$338.0M
Other Short-Term Assets	$2.468B
YoY Change	-11.73%
Inventory	$6.650B
Prepaid Expenses
Receivables	$6.499B
Other Receivables	$0.00
Total Short-Term Assets	$22.66B
YoY Change	-8.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.552B
YoY Change	9.93%
Goodwill	$23.30B
YoY Change	4.48%
Intangibles	$9.282B
YoY Change	-14.45%
Long-Term Investments	$175.0M
YoY Change	-23.25%
Other Assets	$6.527B
YoY Change	21.57%
Total Long-Term Assets	$49.43B
YoY Change	3.07%
TOTAL ASSETS
Total Short-Term Assets	$22.66B
Total Long-Term Assets	$49.43B
Total Assets	$72.09B
YoY Change	-0.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.961B
YoY Change	-4.16%
Accrued Expenses	$6.826B
YoY Change	-1.09%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$1.051B
YoY Change	-5.91%
Total Short-Term Liabilities	$13.04B
YoY Change	-2.42%
LONG-TERM LIABILITIES
Long-Term Debt	$14.48B
YoY Change	-5.36%
Other Long-Term Liabilities	$6.877B
YoY Change	-16.69%
Total Long-Term Liabilities	$14.48B
YoY Change	-5.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.04B
Total Long-Term Liabilities	$14.48B
Total Liabilities	$27.52B
YoY Change	-3.99%
SHAREHOLDERS EQUITY
Retained Earnings	$36.92B
YoY Change	5.14%
Common Stock	$24.73B
YoY Change	0.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$37.48B
YoY Change
Total Liabilities & Shareholders Equity	$72.09B
YoY Change	-0.98%

Cashflow Statement

Concept	2023 Q3
OPERATING ACTIVITIES
Net Income	$1.436B
YoY Change	0.07%
Depreciation, Depletion And Amortization	$824.0M
YoY Change	65.46%
Cash From Operating Activities	$1.877B
YoY Change	-32.48%
INVESTING ACTIVITIES
Capital Expenditures	$560.0M
YoY Change	-219.91%
Acquisitions
YoY Change
Other Investing Activities	-$74.00M
YoY Change	335.29%
Cash From Investing Activities	-$634.0M
YoY Change	30.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.340B
YoY Change	51.65%
NET CHANGE
Cash From Operating Activities	1.877B
Cash From Investing Activities	-634.0M
Cash From Financing Activities	-2.340B
Net Change In Cash	-1.097B
YoY Change	-245.68%
FREE CASH FLOW
Cash From Operating Activities	$1.877B
Capital Expenditures	$560.0M
Free Cash Flow	$1.317B
YoY Change	-59.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	8496000000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1647000000	usd
	us-gaap	Interest Expense InterestExpense	404000000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	83000000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1671000000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	235000000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1436000000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.82
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.82
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1738700000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1748289000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7334000	shares
CY2023Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-1000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	9000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	30000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	80000000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1027000000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-7126000000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	1506000000	usd
CY2023Q3	us-gaap	Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax AociLossCashFlowHedgeCumulativeGainLossAfterTax	152000000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8480000000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6709000000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6499000000	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3847000000	usd
CY2023Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	888000000	usd
CY2023Q3	abt	Prepaid Expense And Other Receivables PrepaidExpenseAndOtherReceivables	2468000000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	22664000000	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	788000000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11559000000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9552000000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9282000000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	23277000000	usd
CY2023Q3	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	6527000000	usd
CY2023Q3	us-gaap	Assets Assets	72090000000	usd
CY2023Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	3961000000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1479000000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5347000000	usd
CY2023Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	886000000	usd
CY2023Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	318000000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	1051000000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	13042000000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8480000000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	37481000000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	213000000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37694000000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	72090000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4129000000	usd
	us-gaap	Depreciation Depreciation	945000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1485000000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	530000000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	424000000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	527000000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1915000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4223000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1447000000	usd
	abt	Payments To Acquire Businesses Net Of Cash Acquired And Research And Development In Process PaymentsToAcquireBusinessesNetOfCashAcquiredAndResearchAndDevelopmentInProcess	877000000	usd
	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	40000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2309000000	usd
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-90000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1447000000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	968000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	133000000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-48000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3173000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9882000000	usd
CY2023Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10143000000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10410000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29868000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33562000000	usd
	abt	Revenue Remaining Performance Obligation Expected Timing Percentage RevenueRemainingPerformanceObligationExpectedTimingPercentage	0.17
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	500000000	usd
	abt	Contract With Customer Liability Change In Unearned Revenue From Cash Received Recognized ContractWithCustomerLiabilityChangeInUnearnedRevenueFromCashReceivedRecognized	346000000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	292000000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	554000000	usd
	us-gaap	Payments For Other Taxes PaymentsForOtherTaxes	1180000000	usd
	us-gaap	Payments For Other Taxes PaymentsForOtherTaxes	987000000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	262000000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	22000000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	25000000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	259000000	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	788000000	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	175000000	usd
CY2023Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	87000000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	23300000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	27500000000	usd
CY2023Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	832000000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4605000000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	496000000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	672000000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2723000000	usd
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	9589000	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1436000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-480000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-409000000	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	338000000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	472000000	usd
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1915000000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	6650000000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21111000000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14477000000	usd
CY2023Q3	abt	Post Employment Obligations Deferred Income Taxes And Other Long Term Liabilities PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilities	6877000000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2400000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1987305154	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	24727000000	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	251246618	shares
CY2023Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	15686000000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	36920000000	usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	45000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-20000000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2668000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5039000000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	560000000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	590000000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-112000000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	305000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2000000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1900000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1700000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1600000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1300000000	usd
	us-gaap	Indefinite Lived Intangible Assets Period Increase Decrease IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease	80000000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	74000000	shares
CY2023Q3	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	367000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	412000000	usd
CY2023Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	750000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	828000000	usd
CY2023Q3	abt	Loss Contingency Range Of Possible Loss Maximum Individual Site LossContingencyRangeOfPossibleLossMaximumIndividualSite	4000000	usd
CY2023Q3	abt	Loss Contingency Range Of Possible Loss Maximum Aggregate Sites LossContingencyRangeOfPossibleLossMaximumAggregateSites	10000000	usd
	abt	Excess Tax Benefit From Share Based Compensation ExcessTaxBenefitFromShareBasedCompensation	11000000	usd
	abt	Excess Tax Benefit From Share Based Compensation ExcessTaxBenefitFromShareBasedCompensation	36000000	usd
	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	59000000	usd
	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	20000000	usd
CY2023Q3	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	55000000	usd
CY2023Q3	abt	Irs Statutory Notice Of Deficiency Claim Amount IRSStatutoryNoticeOfDeficiencyClaimAmount	417000000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10143000000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10410000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29868000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33562000000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1671000000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1758000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4869000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6986000000	usd
	abt	Annual Share Based Awards Recognized In First Quarter Percent AnnualShareBasedAwardsRecognizedInFirstQuarterPercent	0.45
CY2023Q3	abt	Annual Share Based Awards Recognized In First Quarter Percent AnnualShareBasedAwardsRecognizedInFirstQuarterPercent	0.45
CY2022Q3	abt	Annual Share Based Awards Recognized In First Quarter Percent AnnualShareBasedAwardsRecognizedInFirstQuarterPercent	0.45
	abt	Annual Share Based Awards Recognized In First Quarter Percent AnnualShareBasedAwardsRecognizedInFirstQuarterPercent	0.45

Files In Submission

Name	View Source	Status
0001628280-23-035957-index-headers.html	Edgar Link	pending
0001628280-23-035957-index.html	Edgar Link	pending
0001628280-23-035957.txt	Edgar Link	pending
0001628280-23-035957-xbrl.zip	Edgar Link	pending
abt-20230930.htm	Edgar Link	pending
abt-20230930.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
q3202310qex311.htm	Edgar Link	pending
q3202310qex312.htm	Edgar Link	pending
q3202310qex321.htm	Edgar Link	pending
q3202310qex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
abt-20230930_cal.xml	Edgar Link	unprocessable
abt-20230930_def.xml	Edgar Link	unprocessable
abt-20230930_lab.xml	Edgar Link	unprocessable
abt-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
abt-20230930_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ABT
ABBOTT LABORATORIES Stock $abt

2023 Q3 Form 10-Q Financial Statement

#000162828023035957 Filed on November 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ABT ABBOTT LABORATORIES Stock $abt

2023 Q3 Form 10-Q Financial Statement

#000162828023035957 Filed on November 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ABT
ABBOTT LABORATORIES Stock $abt